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Traumatic brain injury is a major cause of death and disability worldwide and often associated with post-
traumatic epilepsy. We recently demonstrated that TBI induces acquired GABAA receptors channelopathy
that associates with hyperexcitability in granule cell layer (GCL). We now assessed the expression of
GABAA and GABAB receptor subunit mRNAs between 6 h and 6 months post-TBI in the hippocampus and
thalamus. The expression of major GABAA receptor subunit mRNAs (a1, a2, a5, b2, b3, g2 and d) was,
often bilaterally, down-regulated in the GCL and in the CA3 pyramidal cells. Instead, expression of a4
(GCL, CA3, CA1), a5 (CA1) and g2 (GCL, CA3, CA1) mRNA was up-regulated after 10 d and/or 4 months.
Many of these changes were reversible. In the thalamus, we found decreases in a1, a4, b2, g2 and
d mRNAs in the laterodorsal thalamus and in the area combining the posterior thalamic nuclear group,
ventroposterolateral and ventroposteromedial complex at 6 h to 4 months post-TBI. Unlike in the hip-
pocampus, thalamic subunit down-regulations were irreversible and limited to the ipsilateral side.
However, contralaterally there was up-regulation of the subunits d and a4 6 h and 4 months after TBI,
respectively. PCR array analysis suggested a mild long-lasting GABAA receptor channelopathy in the GCL
and thalamus after TBI. Whereas TBI induces transient changes in the expression of GABAA receptor
subunits in the hippocampus (presumably representing compensatory mechanisms), alterations of
GABAA receptor subunit mRNAs in the thalamus are long-lasting and related to degeneration of receptor-
containing neurons in thalamo-cortical relay nuclei.
This article is part of the Special Issue entitled ‘GABAergic Signaling in Health and Disease’.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Traumatic brain injury (TBI) is recognized as a major public
health problem worldwide (Finfer and Cohen, 2001; Hyder et al.,
2007). After initial brain damage caused by the direct mechanical
force to the head, secondary neurodegeneration and other pa-
thologies develop over the following days, weeks and months.
These are accompanied bymolecular changes and reorganization of
neuronal networks (Loane and Faden, 2010; McAllister, 2011;
Pitkanen and McIntosh, 2006). As a consequence of brain damageogy, Medical University Inns-
. Tel.: þ43 512900370442;
rexel).
r Ltd. This is an open access articland of cellular plasticity, various co-morbidities, including post-
traumatic epilepsy (PTE) can develop even years after the initial
insult.
TBI has been estimated to cause about 20% of acquired epilepsy
and 5% of all epilepsy (Herman, 2002). In patients with PTE, seizure
onset is most often cortical, including frontal, parietal and polar/
lateral temporal cortices (Gupta et al., 2014; Haltiner et al., 1997;
Lowenstein, 2009) as well as the hippocampus (Mathern et al.,
1994; Swartz et al., 2006). In addition to the damage at the site of
cortical impact, patients with TBI can have remarkable degenera-
tion in thalamic nuclei (Ross and Ebner, 1990; Ross et al., 1993;
Thompson et al., 2005). For example, Ross et al. (1993) reported
up to 75% reduction in the density of neurons in the reticular nu-
cleus of the thalamus. Moreover, neuroimaging studies have
revealed ongoing thalamic damage and microglial reactivity even
17 years after the initial TBI (Ramlackhansingh et al., 2011).e under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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aging (MRI) studies revealed progressive hippocampal and
thalamic damage over a one-year follow-up in rats with TBI
induced by lateral ﬂuid-percussion injury (FPI) (Hayward et al.,
2010; Kharatishvili et al., 2007; Niskanen et al., 2013). Therefore,
lateral FPI reproduces at least some aspects of the hippocampal and
thalamic pathology observed in human TBI and consequently
provides an opportunity to investigate the mechanisms and func-
tional consequences of TBI in more detail (Kawai et al., 1995; Ross
et al., 1995). Interestingly, lateral FPI was reported to induce
marked changes in GABAergic transmission in the hippocampus. At
1 month post-TBI synaptic GABAA receptor-mediated inhibition
was profoundly reduced in the ipsilateral granule cells. Synaptic
inhibition decreased over time, and by 6 months post-TBI became
decreased also contralaterally (Pavlov et al., 2011). Progressive loss
of synaptic inhibition paralleled with a decline in the number of
parvalbumin (PV)-positive interneurons. On the other hand, GABAA
receptor subunit expression was largely unaltered at the chronic
time points (Pavlov et al., 2011).
When investigating the hippocampal changes in the post-TBI
expression of GABAA receptor subunits, we observed marked ab-
normalities also in the expression of many GABAA receptor subunits
in thalamic nuclei. Moreover, we recently reported a marked
reduction in PV/GABA containing neurons of the reticular nucleus
of the thalamus (RT) after TBI (Huusko and Pitkanen, 2014). These
studies kindled us to test further a hypothesis that progressive
changes in GABAA receptor subunits contribute to the development
of post-TBI hyperexcitability. Consequently, the present study was
designed to assess in more details the temporo-spatial evolution of
abnormalities in 12 GABAA receptor subunits over a 6 h to 4months
post-TBI follow-up. Moreover, we compared the receptor changesFig. 1. Severe neuronal damage in the thalamus but not in the hippocampus after lateral FPI.
a minor loss of principal cells. The thalamus, however, showed a clear damage already at 24 h
of CCK mRNA. No change was observed in the hippocampus. However, we found a decreas
months follow-up. In the contralateral thalamus (blue; i), we found increased level of CCK
In the CA1 pyramidal cell layer of the hippocampus there was no decrease in CCK mRNA
rows denote damage in the thalamic nuclei. Scale bar ¼ 250 mm (aeh). Statistical signiﬁca
cholecystokinin; LD, laterodorsal thalamic nucleus; PO, posterior thalamic nuclear group; VP
of the references to color in this ﬁgure legend, the reader is referred to the web version ofin the hippocampus and thalamus, the two areas showing patho-
logic changes after TBI and involved in candidate networks
becoming epileptogenic after TBI.
2. Materials and methods
2.1. Animals
Adult male SpragueeDawley rats (body weight 298e369 g at the time of injury;
Harlan Netherlands B.V., Horst, Netherlands) were used in the study. The rats were
individually housed in a controlled environment (temperature 22 ± 1 C; 50e60%
humidity; lights on from 07:00 to 19:00). They had access to food and water ad
libitum. All animal experiments were conducted in accordancewith the guidelines of
the European Community Council Directives 86/609/EEC and approved by the
Committee for Welfare of Laboratory Animals of the University of Eastern Finland.
Traumatic brain injury (TBI) was induced using lateral FPI in three cohorts of
animals fromwhich 34were anticipated for in situ hybridization, 30 for RT-PCR array
and 21 for immunohistochemistry. From the surviving rats, in the present study 24
were used for in situ hybridization, 5 for RT-PCR array and 16 for immunohisto-
chemistry (see Supplementary Fig. 1). Brieﬂy, animals were anesthetized and placed
in a Kopf stereotactic frame (David Kopf Instruments, Tujunga, CA, USA) and the
skull was exposed. Thereafter, a circular craniectomy (Ø 5 mm) was performed over
the left parietal lobe midway between lambda and bregma, leaving the dura intact.
Lateral FPI was induced after connecting the rat to a ﬂuid-percussion device
(AmScien Instruments, Richmond, VA, USA). The mean severity of the impact was
3.45 ± 0.01 atm in a cohort used for in situ hybridization study, 3.38 ± 0.01 atm in a
cohort used for PCR array study and 3.38 ± 0.02 atm in a cohort used for immu-
nohistochemistry (no difference between the groups). Thirty rats underwent sham
operation, that is, they underwent all surgical procedures without the exposure to
impact, and were used as controls.
2.2. In situ hybridization
2.2.1. Tissue processing
Rats were killed at 6 h, 24 h, 10 days, or 4 months (6 animals per group) after TBI
by cervical dislocation. The brains were dissected and snap frozen by immersion in
isopentane cooled to 70 C. Isopentane was then allowed to evaporate at 70 C,
the brains were then sealed in plastic vials, and kept at 70 C until further pro-
cessed. Brains from control animals were sampled at 24 h (n ¼ 5) and 4 months(aed) Nissl staining revealed shrinkage of the hippocampus which was associated with
post-TBI which progressed over the 4-month follow-up. (eej) Quantitative assessment
e in the ipsilateral thalamus already at 24 h post-TBI (red; i), progressing over the 4-
mRNA at 6 h post-TBI as compared to controls which normalized by 24 h post-TBI.
(eeh, j). The LD and PO/VPM/VPL groups are outlined in control sections (a, e). Ar-
nce: *p < 0.05, **p < 0.01, ***p < 0.001 as compared to controls. Abbreviations: CCK,
M, ventroposteromedial nucleus; VPL, ventroposterolateral nucleus. (For interpretation
this article.)
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sections were cut using a cryostat (Microm HM 560 M, Carl Zeiss AG, Vienna,
Austria) at 20 C, thaw-mounted on silane-coated slides, and stored at 70 C.
Every 11th section was stained with Cresyl violet, dehydrated, cleared in butyl ac-
etate, and coverslipped using Eukitt mounting medium (O. Kindler GmbH, Freiburg,
Germany). Cresyl violet stained sections were used to match the coronal levels in
different rat brains to be sampled for in situ hybridization and histochemistry.2.2.2. In situ hybridization
Sections from each rat sampled from the same rostro-caudal level (AP 3.30
to 4.15 from the bregma for GABAA receptor subunits, CCK, PV and GAD1 and
AP 4.16 to 4.40 for GABAB receptor subunits) were processed for in situ hybrid-
ization in the same incubation. The sequences of custom-synthesized oligonucleo-
tides (Microsynth AG, Balgach, Switzerland) complementary to the respective
mRNAs for GABAA receptor subunits and two GABAB receptor isoforms GABAB1 and
GABAB2 have been listed previously (Drexel et al., 2013; Furtinger et al., 2003b;
Tsunashima et al., 1997). As marker for GABA-ergic neurons of the reticular
thalamic nucleus we determined glutamate decarboxylase1 (GAD1) and parvalbu-
min (PV) mRNAs and cholecystokinin-octapeptide (CCK) mRNA for principal neu-
rons in the in the laterodorsal and posterior thalamic nuclei (for details see 2.2.3.).
For PV mRNA the probe previously described was used (Drexel et al., 2011). For
GAD1, an oligonucleotide complementary to bases 795e843 (NM_017007.1; CAC
GGGTGC AAT TTC ATATGT GAACATATT GGTATT GGC AGT TGATGT C) and for CCK-8
an oligonucleotide complementary to bases 387e419 (NM_012829.2, GAA ATC CAT
CCA GCC CAT GTA GTC CCG GTC ACT) of the respective rat genes was used.
In situ hybridization was performed as described previously (Tsunashima et al.,
1997). Brieﬂy, the oligonucleotides (2.5 pmol) were labeled at the 3ʹ-end with [35S]
a-thio-dATP (1300 Ci/mmol; New England Nuclear, Boston, MA, USA) by reaction
with terminal deoxynucleotidyltransferase (Roche Austria GmbH, Vienna, Austria)
and precipitated with 75% ethanol and 0.4% NaCl. Frozen sections (20 mm) were
immersed in ice-cold paraformaldehyde (2%) in phosphate-buffered saline (PBS), pH
7.2 for 10 min, rinsed in PBS, immersed in acetic anhydride (0.25% in 0.1 mol/l
triethylamine hydrochloride) at room temperature for 10 min, dehydrated by
ethanol series, and delipidated with chloroform. The sections were then hybridized
in 50 ml hybridization buffer containing about 50 fmol (0.8e1  106 cpm) labeled
oligonucleotide probe for 18 h at 42 C. The hybridization buffer consisted of 50%
formamide (Merck, Darmstadt, Germany), 2xSSC (1xSSC consisting of 150 mmol/l
NaCl and 15 mmol/l sodium citrate, pH 7.2). The sections were thenwashed twice in
50% formamide in 1xSSC (42 C, 4 15 min), brieﬂy rinsed in 1xSSC, rinsed inwater,
dipped in 70% ethanol, dried, and then exposed to BioMaxMR ﬁlms (SigmaeAldrich,
Vienna, Austria) together with [14C]-microscales (Amersham, Buckinghamshire, UK)
for 14e28 d. Films were developed using Kodak D19 developer (SigmaeAldrich,
Vienna, Austria).2.2.3. Densitometric analysis of mRNA expression
Autoradiographic ﬁlms were digitized and analyzed using NIH ImageJ software
(version 1.46; U.S. National Institutes of Health, Bethesda, ML, USA; http://imagej.
nih.gov/ij/). The 6 regions of interest (ROIs) included (i) granule cell layer of den-
tate gyrus, (ii) CA1 pyramidal cell layer of the hippocampus proper, (iii) CA3 pyra-
midal cell layer, (iv) laterodorsal (LD) thalamus, (v) area combining the posterior
thalamic nuclear group (PO), ventroposterolateral (VPL) and ventroposteromedial
(VPM) complex (PO/VPM/VPL), and (vi) reticular nucleus (RT) of the thalamus
(Swanson, 1992).
Brieﬂy, in the dentate gyrus or the hippocampus, a line (20 pixels wide) was
drawn perpendicular to the layer of interest, and a density proﬁle of gray values was
plotted in ImageJ using the function “Analyze e Plot proﬁle”. To assess gene
expression in the thalamus, a circular region of interest (diameter 0.9e2.1 mm) was
placed over the thalamic region of interest, and the mean gray values were plotted.
Then, the relative optical densities (RODs) were calculated according to the
following formula: ROD ¼ log[256/(255  mean gray value)]. Background RODs
were calculated from gray values determined in the internal capsule of the same
section and subtracted. Thereafter, it was conﬁrmed that the range of RODs was
within the linear range of autoradiography standards.Fig. 2. a and b. Time courses of changes in the expression of GABAA receptor subunit mRNAs
peq and 2b: aeb; feg; kel, peq) Representative photomicrographs demonstrating the level o
cee; hej; meo, res) Optic densities for mRNA levels were determined by image analysis (s
(ROD) in the granule cell layer (GCL) and pyramidal cell layers are depicted as red lines for ip
interest examined are indicated in a representative way for the laterodorsal nucleus (LD) an
(VPL) and ventroposteromedial (VPM) complex (PO/VPM/VPL) (Swanson, 1992) with red circ
and hippocampal subﬁelds CA1 and CA3 (nomenclature according to Swanson, 1992). Note
intervals after TBI (6 h and/or 24 h). However, the mRNA levels mainly recover close to contr
levels of a4 and a5 4 months after TBI in sector CA1 indicating reﬂectory adaptation. Sca
***p < 0.001 as compared to controls. Abbreviations: GCL, granule cell layer. (For interpreta
version of this article.)2.3. Expression of GABAA receptor subunits, Gad1 and Gad2 by RT-PCR in the
hippocampal principal cells and thalamus after TBI
2.3.1. Tissue preparation
Rats (5 TBI and 5 controls) were deeply anesthetized with an intraperitoneal
(i.p.) injection of a solution (6 ml/kg) containing sodium pentobarbital (58 mg/kg),
chloral hydrate (60 mg/kg), magnesium sulfate (127.2 mg/kg), propylene glycol
(42.8%) and absolute ethanol (11.6%) and transcardially perfused at 6 months after
TBI with 0.9% NaCl (30 ml/min, 4 C, for 4 min) to remove blood from the tissue. The
brain was quickly removed from the skull, hemispheres were separated, and each
one was placed to its own cryomold (#4557, Tissue-Tek, Sakura Finetek, Torrance,
CA, USA) on ice (4 C). Thereafter, ice cold optimum cutting temperature formulation
(O.C.T., #4583, Tissue-Tek, Sakura Finetek) was added to the cryomolds to cover the
entire sample. Cryomolds were snap frozen in isopentane, chilled with dry ice, and
stored at 70 C until further processed.
2.3.2. Laser capture microdissection (LCM)
Coronal 8-mm-thick sections were cut with a cryostat (Leica CM3050 S, Leica
Microsystems Nussloch GmbH, Germany) from the ipsilateral septal hippocampus at
the level between 2.3 and 3.8 mm from the bregma (Swanson, 1992).
Twenty-ﬁve sections were randomly selected and moved to LCM slides
(#11505151, Leica, MicroDissect GmbH, Herborn, Germany). Sections were stored
at 70 C for a maximum time of 48 h before further treatment.
Sections were stained with Cresyl violet (Merck, Darmstadt, Germany) to
recognize different layers of the hippocampus. Brieﬂy, sections were placed to 96%
ethanol for 30 s, then 70% ethanol for 30 s, 50% ethanol for 30 s, and ﬁnally, to 1%
Cresyl violet in 100% ethanol for 20 s. After that, sections were moved to 50% ethanol
for 30 s, 70% ethanol for 30 s, 96% ethanol for 30 s and 100% ethanol for 30 s. Sections
were rinsed in xylene twice for 5 min. Finally, slides were dried in a hood for 20min.
LCM was performed immediately after Cresyl violet staining. The granule cell
layer of the dentate gyrus and pyramidal layer of the CA1 were microdissected with
a Leica LMD Laser Microdissection System (Leica, Wetzlar, Germany) in extraction
buffer from the Arcturus® PicoPure® RNA Isolation Kit (Applied Biosystems, Foster
City, CA, USA). Extraction buffer containing microdissected cells was vortexed and
incubated for 30 min at 42 C. After incubation, cell extract was centrifuged at
800  g for 2 min and stored at 70 C.
Methodology for microdissection of the thalamus has been described previously
(Huusko and Pitkanen, 2014).
2.3.3. RT-PCR array
RNA isolationwas performed according to themanufacturer's protocol (PicoPure
RNA User Guide, Part Number 12682-00ARC Rev A, Carlsbad, CA, USA). Endogenous
DNA was removed using the RNase-Free DNase Set (Qiagen, Hilden, Germany). RNA
concentration and quality was measured with a NanoDrop 1000 spectrophotometer
(Thermo Fisher Scientiﬁc, Wilmington, DE, USA). First strand cDNA synthesis was
donewith an RT2 First StrandKit (C-03, SABiosciences, Frederick,MD, USA) according
to user manual (Part #1022A Version 5.01, SABiosciences) using 70 ng of RNA.
Gene expression of GABAA receptor subunits, Gad1 and Gad2was assessed using
RT2Proﬁler™ PCR ArrayRat Neurotransmitter Receptors and Regulators array (PARN-
060C, SABiosciences). Brieﬂy, template cDNA was mixed with RT2SYBR Green/ROX
qPCR Master Mix (SABiosciences) and moved to the RT2Proﬁler™ PCR Array plate
(SABiosciences). The program for PCR was as follows (StepOne Software v2.1,
Applied Biosystems, Foster City, CA, USA): 1 cycle (95 C, 10 min), 40 cycles (95 C,
15 s; 60 C, 60 s) in a StepOnePlus™ Real-Time PCR System (Applied Biosystems).
2.4. Immunohistochemistry
2.4.1. Tissue processing
Rats were perfused for immunohistochemistry at 6 h, 24 h, 10 d, or 4 months
after TBI (four rats per group). Control animals were perfused at 24 h or 4 months (4
rats each time point) after sham-operation. Brieﬂy, rats were deeply anesthetized
with an i.p. injection of the same solution used for animals in a cohort of rats for PCR
array and perfused through the ascending aorta with 50 ml PBS (50 mM phosphate
buffer, pH 7.4, in 0.9% NaCl) followed by 200 ml 4% paraformaldehyde in PBS as
described previously (Drexel et al., 2011). Brains were immediately removed from
the skull and postﬁxed in the same ﬁxative for 90 min at 4e8 C. Subsequentlyin the hippocampus and thalamus (a1, a2, a4, a5, b2, b3, g2 and d). (2a: aeb; feg; kel,
f GABAA receptor subunit mRNAs in the hippocampus. (2a: cee; hej; meo, ret and 2b:
ee Methods) of ﬁlm autoradiographs after in situ hybridization. Relative optic densities
silateral side after TBI and as blue lines for contralateral side after TBI. In k the areas of
d the area combining the posterior thalamic nuclear group (PO), ventroposterolateral
les and the location where the line scans were set are shown with blue arrows for GCL
that mRNA levels for all other subunits except a4 decrease bilaterally at the early time
ol values on both sides within 4 months. Subunit g2 mRNA level increases 10 days and
le bar ¼ 250 mm (aeb, feg. kel, peq). Statistical signiﬁcance: *p < 0.05, **p < 0.01,
tion of the references to color in this ﬁgure legend, the reader is referred to the web
Fig. 3. Time courses of changes in the expression of GABAA receptor subunit mRNAs that are primarily expressed in the LD and PO/VPM/VPL complex (a1, a4, b2, g2 and d). (aec,
feh, kem, per, uew) On the left side we present representative images of ﬁlm autoradiographs after in situ hybridization for the respective GABAA receptor subunit mRNAs. (dee,
iej, neo, set, xey) Quantitative evaluation of relative optic densities (ROD) and respective statistics are shown on the right panels. ROD values are depicted as red (ipsilateral to TBI)
and blue (contralateral to TBI) lines. Note the rapid decreases in most subunit mRNAs ipsilaterally. Interestingly, the mRNA expression remains mostly unchanged in the contra-
lateral side. Signiﬁcant increases were observed for the a4 subunit mRNA on the contralateral side at the late intervals and for d subunit mRNA in both hemispheres after 6 h,
respectively. Scale bar ¼ 250 mm (aec, feh, kem, per, uew). Statistical signiﬁcance: *p < 0.05, **p < 0.01, ***p < 0.001 as compared to controls. Abbreviations: LD, laterodorsal
thalamic nucleus; PO, posterior thalamic nuclear group; VPM, ventroposteromedial nucleus; VPL, ventroposterolateral nucleus. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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Brains were sealed in vials containing 20% sucrose and sent from Kuopio to Inns-
bruck. There the brains were rapidly frozen by immersion in 70 C isopentane for
3 min. After letting the isopentane evaporate, brains were stored in tightly sealed
vials at 70 C.
2.4.2. Immunohistochemistry
Immunohistochemistry for GABAA receptor subunits was done for free ﬂoating
sections (30-mm-thick) as described previously (Pirker et al., 2000; Sperk et al.,
1997). Afﬁnity puriﬁed antisera raised in rabbits against fusion proteins of peptide
sequences (speciﬁc for the individual subunits) were used at the given concentra-
tions and as described in detail previously (Pirker et al., 2000; Sperk et al., 1997).
Goat anti-rabbit antibody coupled to horse radish peroxidase (P0448, Daco, Vienna)
was used as secondary antibody (1:250) with subsequent labeling by reaction with
3,3-diaminobenzidine.
2.5. Statistical analysis
In situ hybridization datawas analyzed using GraphPad Prism 5.0a for Macintosh
(GraphPad Software, San Diego, CA, USA). Analysis of variance (ANOVA) with Dun-
nett's multiple comparison post hoc test was used to analyze between-group dif-
ferences among multiple sets of data. All data are presented as mean ± SEM. PCR
Array analysis was done using a web-based data analysis tool (http://www.
sabiosciences.com/pcrarraydataanalysis.php). Unsupervised hierarchical clusteringof the GABAA receptor subunits, Gad1 and Gad2was performed using the same data
analysis tool and is presented as a heat map with dendrograms indicating co-
regulated genes across groups or individual samples. Statistical signiﬁcance was
deﬁned as p < 0.05.
3. Results
3.1. Mortality
Mortality during ﬁrst 48 h after TBI was 26% (9/33) in a cohort of
animals for in situ hybridization, 27% (8/30) in a cohort of the an-
imals used for PCR array study and 25% (5/20) in a cohort of animals
used for immunohistochemistry (see Supplementary Fig. 1).
3.2. Neurodegeneration and regulation of expression of GABAA
receptor subunits in the hippocampus after FPI
3.2.1. Neurodegeneration
Analysis of Nissl-stained preparations revealed hippocampal
shrinkage ipsilaterally at 10 d and 4 months post-TBI (Fig. 1ced).
Fig. 4. Changes in the immunoreactivities for subunits a4, b2, d and a3 after lateral FPI.
(a, c, e, g) Representative immunostained sections from a control rat (b, d, f) Note the
persistent decreases in a4, b2 and d subunit expression 4 months after TBI in the
thalamic areas investigated. There was also a clear increase in a4 subunit protein in the
LD and PO/VPM/VPL on the side contralateral to the injury (b). Arrows in g and h
denote labeling of the reticular thalamic nucleus for a3 immunoreactivity. Scale bars in
f (for aef) and in h (for g and h): 250 mm.
M. Drexel et al. / Neuropharmacology 88 (2015) 122e133 127However, this was not associated with any remarkable loss of
principal cells in the dentate gyrus or in the hippocampus proper.
Accordingly, semiquantitative analysis of expression of CCK mRNA
as a marker of CA1 pyramidal cells (Gruber et al., 1993) showed that
the level of expression at 10 d and 4 months was comparable be-
tween injured and control rats both ipsilaterally and contralaterally
(Fig. 1j). Interestingly, however, we found a temporary up-
regulation of CCK mRNA in the CA1 at 6 h post-TBI both ipsilater-
ally (147 ± 4% as compared to that in controls, p < 0.001; Fig. 1f) and
contralaterally (136 ± 6%, p < 0.001; Fig. 1f).
3.2.2. Expression of GABAA receptor subunits
Time course of changes in the expression of GABAA receptor
subunit mRNAs in the different hippocampal subﬁelds is summa-
rized in Fig. 2a and b. The most pronounced changes were seen in
the granule cell layer of the ipsilateral dentate gyrus, in which the
TBI induced a prominent decrease in the expression of mRNAs for
a1 (55 ± 10% of that in controls, p < 0.001), a2 (48 ± 4%, p < 0.001),
a5 (21 ± 5%, p < 0.001), b2 (62 ± 5%, p < 0.01), b3 (53 ± 5%,
p < 0.001), and d (25 ± 2% p < 0.001) subunits already at 6 and 24 h
post-TBI. Expression of g2 subunit was decreased at 6 h (65 ± 5%,
p < 0.001) post-TBI. Importantly, the expression of all GABAA re-
ceptor subunit mRNAs returned to control level by 4 months post-
TBI. Interestingly, comparable transient down-regulation (30e77%
of that in controls, p < 0.01) of GABAA receptor subunits (except a1
mRNA) was also found contralaterally in the granule cell layer.
Unlike the other GABAA receptor subunits, the level of a4 mRNA
was increased at 6 h (ipsilaterally: 140 ± 28% as compared to that in
controls, p > 0.05; contralaterally: 177 ± 27% as compared to con-
trols, p < 0.01) and 4 months (ipsilaterally: 171 ± 12%, p < 0.05;
contralaterally: 195 ± 7%, p < 0.001) post-TBI in granule cell layer
both ipsilaterally and contralaterally.
Similar to granule cell layer, we found a transient down-
regulation in the expression of a1 (40 ± 8% of that in controls,
p < 0.001), a2 (50 ± 8%, p < 0.001), a5 (62 ± 7%, p < 0.01), b2
(34 ± 6%, p < 0.001), b3 (52 ± 6%, p < 0.001) and g2 (71 ± 7%,
p < 0.05) mRNAs in the CA3 pyramidal cell layer at 6 h and 10 d
post-injury (Fig. 2a and b). Contralaterally, the subunit expression
was comparable to that in controls except of that of a4. It showed a
tendency to be bilaterally up-regulated in sectors CA3 and CA1 at
10 d (p > 0.05) and was up-regulated bilaterally (CA3 ipsilaterally:
131 ± 22% of that in controls, not signiﬁcant; CA3 contralaterally:
224 ± 31%, p < 0.01; CA1 ipsilaterally: 161 ± 6%, p < 0.05; CA1
contralaterally: 200 ± 18%, p < 0.01) at 4 months post-TBI. Also the
expression of a5 mRNA was up-regulated contralaterally in sector
CA1 at 4 months post-TBI (134 ± 8% of that in controls, p < 0.01)
(Fig. 2a).
3.3. Neurodegeneration and regulation of expression of GABAA
receptor subunits in the thalamus
3.3.1. Neurodegeneration
Analysis of Nissl-stained sections revealed progressive damage
in the LD and PO/VPM/VPL starting at 24 h post-TBI (Fig. 1bed).
Accordingly, expression of CCK mRNA at 24 h post-injury was
reduced to 64 ± 7% of that in controls in the LD (p < 0.05) and there
was a trend towards reduced levels also in the PO/VPM/VPL
(75 ± 6% of that in controls, p > 0.05). The loss progressed to almost
entire reduction (to 59 ± 5% of that in controls in the LD after 4
months (p < 0.01) and to 18 ± 6% in the PO/VPM/VPL after 10 d,
p < 0.001) of the thalamic nuclei ipsilateral to TBI after 10 d and 4
months (Fig. 1geh). Contralateral to TBI, levels of CCK mRNA were
comparable to that in controls both in the LD and PO/VPM/VPL at
the late time intervals. However, similar to the hippocampus, we
found a remarkable up-regulation of CCK mRNA at 6 h post-TBI inthe PO/VPM/VPL ipsilaterally (139 ± 4% as compared to that in
controls, p < 0.001), and both in the LD (171 ± 2%, p < 0.001) and
PO/VPM/VPL contralaterally (157 ± 3%, p < 0.001; Fig. 1i).
3.3.2. Expression of GABAA receptor subunits
GABAA receptor subunits were differently distributed in the
thalamic nuclei investigated. Whereas the LD and PO/VPM/VPL
complex showed a high level of expression of a1, a4, b2, g2 and
d subunits, the reticular nucleus was rich of a3, b3 and g2 subunits
(Sperk et al., 1997; Tsunashima et al., 1997).
Representative examples of ﬁlm autoradiographs showing the
distribution of GABAA receptor subunit mRNAs in the LD and PO/
VPM/VPL at 10 d and 4 months post-TBI are shown in Fig. 3. On the
injured side there was a progressive decrease of 5 GABAA receptor
subunit mRNAs for up to 10 days post-TBI (Fig. 3). Interestingly the
decrease in mRNAs of different subunits was not uniform. At 6 h
and 24 h post-TBI there were no remarkable decreases in a1, b2 or
g2 mRNAs in the PO/VPM/VPL (Fig. 3e, o, t) and in g2 mRNA in the
LD (Fig. 3s). On the other hand, levels of a1, a4 and b2 decreased to
35e55% of that in controls in the LD already at 6 he24 h post-TBI
(p < 0.001)(Fig. 3d, i, n). At 4 months post-TBI, however, the
levels of all subunit mRNAs were increased towards the control
levels. The levels of a4 mRNA had reached the control level in the
both nuclei (Fig. 3i, j). Contralaterally, the levels of a1, b2 and g2 did
not change over the 4-months follow-up. However, at 10 d and 4
Fig. 5. Time courses of changes in the expression of GABAB1 (GBBR1) and GABAB2 (GBBR2) receptor subunit mRNAs in the hippocampus and LD and PO/VPM/VPL nuclei of the
thalamus after TBI. Panels aed and eeh show photomicrographs of autoradiographies after in situ hybridization for GABAB1 and GABAB2, respectively. Analysis was done from
sections caudal to those used for analysis of GABAA receptor subunits and GAD1. Panels Ien show the respective relative optic densities (ROD) in the granule cell layer (GC) and CA1
pyramidal cell layer of the hippocampus and in the PO/VPM/VPL. Besides a transient bilateral up-regulation of GABAB2 mRNA in the granule cell layer 6 h after TBI, we did not
observe a signiﬁcant change in GABAB receptor subunits in the hippocampus during the 4-months follow-up after TBI. The marked unilateral decrease of GABAB1 and GABAB2
subunit mRNAs in the LD and PO/VPM/VPL likely reﬂects underlying neuronal damage in these areas. Scale bar in h: 250 mm. Statistics: *p < 0.05, **p < 0.01, ***p < 0.001 vs. control.
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mRNA in the LD (165 ± 34%, p < 0.05 and 169 ± 9%, p < 0.01) as well
as in the PO/VPM/VPL (147 ± 34%, p > 0.05, and 166 ± 15%, p < 0.05)
(Fig. 2i, j). Similarly, d mRNA was transiently up-regulated 6 h (LD:
119 ± 6%, p < 0.05; PO/VPM/VPL: 124 ± 6% as compared to controls,
p < 0.01) after TBI.
Fig. 4 shows examples of immunostainings for a4, b2 and
d subunits. In line with in situ hybridization, we found a persistent
decrease in labeling of a4, b2 and d subunit expression at 4 months
post-TBI in the LD and PO/VPM/VPL (Fig. 4b, d, f). As expected,
immunoreactivity for a4 subunit was increased in the contralateral
LD and PO/VPM/VPL (Fig. 4b).3.4. Expression of GABAB receptor subunits is affected in the
thalamus but not in the hippocampus
We also investigated mRNA levels of the two GABAB receptor
isoforms, GABAB1 and GABAB2 in the thalamus and the hippocam-
pus. Both receptors are thought to be present as heterodimers in
the membrane (Gassmann and Bettler, 2012). Analysis was done in
sections caudal to those used for analysis of GABAA receptor sub-
units, and contained either PO alone or the entire PO/VPM/VPL
complex. Expression of subunit mRNAs did not differ between POand VPM/VPL. Consequently, the three nuclei were analyzed
together as we pooled the data of our measurements. In the ipsi-
lateral granule cell layer, we found a transient increase (122 ± 6% of
that in controls, p < 0.05) in GABAB2 receptor mRNA at 6 h and in
the CA3 a mild decrease (79 ± 9% as compared to controls, p < 0.05)
at 4 months post-TBI (Fig. 5). Contralaterally, only a transient in-
crease of the GABAB2 mRNA was found at 6 h post-TBI (125 ± 8% of
that in controls, p < 0.05; Fig. 5). There was decreased expression of
GABAB1 and GABAB2 receptors in the PO/VPM/VPL (30e66% of that
in controls) ipsilaterally in all investigated time points after TBI
(p < 0.01).3.5. Expression of GAD1, PV and of subunit a3 mRNAs in the
reticular nucleus of the thalamus
To expand our previous studies in the hippocampus and thal-
amus (Huusko and Pitkanen, 2014; Pavlov et al., 2011), we inves-
tigated two presynaptic (PV and GAD1 mRNAs) and one
postsynaptic marker (a3 mRNA) of GABAergic circuitries in the RT.
Like in the hippocampus, the mRNA levels of PV and GAD1 were
only 40e50% (10 d and 4 m) and about 40% (4 m) of that in controls
in the RT, respectively (p < 0.001; Fig. 6d, h). In contrast, there was
no signiﬁcant change in a3 mRNA expression (Fig. 6l).
Fig. 6. Changes in the expression of parvalbumin, glutamate decarboxylase1 (GAD1) and the a3 subunit mRNAs in the reticular nucleus of the thalamus. Panels on the left show
autoradiographic images of in situ hybridization for parvalbumin, glutamate decarboxylase1 (GAD1) and the a3 subunit mRNAs. Right side panels show relative optic densities
(ROD) in the reticular thalamic nucleus (arrows). Note the decreases in all three mRNAs ipsilateral to TBI. Scale bar ¼ 250 mm (aec, eeg, iek). Statistical signiﬁcance: *p < 0.05,
***p < 0.001 as compared to controls. Abbreviations: GAD1, Glutamate decarboxylase1; PV, parvalbumin; RT, reticular nucleus of the thalamus.
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Gad2 at 6 months post-TBI
In the granule cell layer, we found a 1.2-fold up-regulation of the
expression of Gabrb3 (p < 0.05; Table 1). In addition, both Gad1 and
Gad2 genes were down-regulated (0.66-fold, p < 0.05 and 0.60,
p < 0.01; respectively). In the pyramidal cell layer of the CA1, we did
not ﬁnd any changes in the expression of GABAA receptor subunits,
Gad1 or Gad2 (Table 1).
Results from the gene expression analysis of the GABAA receptor
subunits in the thalamus (down-regulation of ε and q) have been
presented elsewhere (Huusko and Pitkanen, 2014). Reanalysis of
data on array revealed also a 0.70-fold down-regulation of Gad1
(p < 0.05) in the thalamus (Table 1).
Interestingly, when individual subunits were analyzed sepa-
rately, only few of them reached the level of statistical signiﬁcance
after TBI as compared to controls. However, when we performed
unsupervised hierarchical clustering analysis of all GABAA receptor
subunits, Gad1 and Gad2, we were able to see a pattern in the
change of subunit gene expression level after TBI, particularly in the
granule cell layer (Fig. 7). Noteworthy, clustering analysis also
separated granule cell layer, CA1 and thalamus according the
GABAA receptor subunit gene expression level.4. Discussion
The loss of presynaptic GABAergic terminals has been shown to
result in reduced neurotransmitter release and abnormal expres-
sion of GABAA receptor subunits in postsynaptic neurons, which
can contribute to the neuronal hyperexcitability (Zhang et al.,
2007). Moreover, analysis of the tissue from patients withtemporal lobe epilepsy (TLE) has revealed interneuron loss which is
associated with changes in the expression of GABAA receptor sub-
units (Loup et al., 2000; Pirker et al., 2003). Based on these data, we
hypothesized those progressive changes in GABA receptor subunits
can contribute to the development of post-TBI hyperexcitability.We
have ﬁve main ﬁndings: 1) There was a transient bilateral down-
regulation of different GABAA receptor subunits in the dentate gy-
rus and hippocampal subﬁelds. Only exception was a4-subunit
which gene expression was up-regulated in acute and chronic
time points after TBI. 2) In the thalamus the down-regulation of the
subunit genes progressed ipsilaterally towards longer time points
after insult. 3) There was a down-regulation of GABAB1 and GABAB2
in the thalamus after TBI. The mRNA levels assessed from granule
cell layer or CA3 subﬁeld of the hippocampus were close to control
values in all investigated time points. 4) As consistent to our pre-
vious study, the levels of the PV and GAD1 mRNAwere lower in the
RT as compared to controls. 5) PCR array analysis of the GABAA
receptor subunits reproduced well the ﬁndings obtained using the
in situ hybridization. Only few signiﬁcant changes in the subunit
level were found. However, interestingly, the clustering analysis
revealed different patterns in the subunit gene expression between
TBI animals and controls in the granule cell layer of the dentate
gyrus and thalamus suggesting mild, long-lasting channelopathy
after TBI.4.1. Alterations in GABAA receptor subunit gene expression is long-
lasting in the thalamus but transient in the hippocampus after
lateral FPI
The GABAA receptors are the main mediator of fast inhibitory
neurotransmission in the adult central nervous system (CNS)
Table 1
Expression of GABAA receptor subunits, Gad1 and Gad2 at 6 months after TBI.
Subﬁeld Gene code Fold change p-value
Granule cell layer Gabra1 1.12 0.348
Gabra2 1.11 0.439
Gabra3 1.13 0.417
Gabra4 1.00 0.931
Gabra5 1.05 0.674
Gabra6 0.80 0.690
Gabrb2 1.04 0.617
Gabrb3 1.17* 0.036
Gabrd 1.32 0.058
Gabre 2.78 0.105
Gabrg1 1.95 0.107
Gabrg2 1.13 0.127
Gabrp 0.74 0.788
Gabrq 3.78 0.327
Gabrr1 0.96 0.639
Gabrr2 0.91 0.848
Gad1 0.66* 0.024
Gad2 0.60** 0.001
Pyramidal cell layer of the CA1 Gabra1 0.71 0.201
Gabra2 0.91 0.571
Gabra3 0.81 0.355
Gabra4 0.73 0.239
Gabra5 0.73 0.115
Gabra6 0.82 0.438
Gabrb2 0.74 0.461
Gabrb3 0.72 0.204
Gabrd 0.74 0.356
Gabre 0.60 0.405
Gabrg1 0.92 0.560
Gabrg2 0.78 0.234
Gabrp 0.36 0.238
Gabrq 0.50 0.325
Gabrr1 0.63 0.150
Gabrr2 0.77 0.814
Gad1 0.89 0.509
Gad2 0.85 0.421
Thalamus Gad1 0.70* 0.013
Gad2 0.84 0.154
Statistical signiﬁcance: *p < 0.05; **p < 0.01, as compared to controls.
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glycoprotein formed by ﬁve different subunits (a 1e6, b 1e3, g 1e3,
d, r 1e3, ε, q, p) which properties depend on the subunit combi-
nation (Campagna-Slater and Weaver, 2007; Fritschy and Brunig,
2003; Mohler et al., 1998; Sieghart and Sperk, 2002). TBI caused
rapid (6e24 h (after 6e24 h) decreases in all major subunits a1, a2,
a5, b1, b2, b3, g2 and d (with the exception of a4) in the dentate
gyrus and in sector CA3 of the hippocampus and in the thalamus
(subunits a1, a4, b2, and d with the exception of g2 in LD and PO/
VPM/VPL and b2 in PO/VPM/VPL) at the injured side. Whereas in
the dentate gyrus and hippocampus proper the expression of all
subunits investigated recovered already after 10 days back to con-
trol level decreases in GABAA receptor subunits progressed and
were maximal (up to 85%) 10 days after lateral FPI.
Analysis of tissue resections from patients with TLE have
revealed altered GABAA receptor subunit expression patterns i.e.
there is greater labeling of the a2, g2, b2 and b3 subunits (Loup
et al., 2000; Pirker et al., 2003). Many laboratories have demon-
strated the altered expression of GABAA receptor subunits in rat
models of acquired epilepsy induced by SE (Brooks-Kayal et al.,
1998; Friedman et al., 1994; Fritschy et al., 1999; Schwarzer et al.,
1997; Sperk et al., 1998; Tsunashima et al., 1997). However, the
gene expression patterns have been found to depend on the SE
model used and the time point post-SE when sampling was done.
In addition to our previous studies (Huusko and Pitkanen, 2014;
Pavlov et al., 2011), three other laboratories have investigated ac-
quired GABAA receptor channelopathy after TBI. Gibson et al. (2010)induced TBI by using central FPI in adult SpragueeDawley rats.
These investigators measured the levels of the hippocampal GABAA
receptors using western blot at 3 h, 6 h, 24 h or 7 d post-TBI. The
level of a1 was increased by about 125% at 3 h and 6 h post-TBI of
that in controls, but later it declined (50%). The protein level of the
a3 was reduced to 75% only at 24 h post-TBI. The b3 level was ﬁrst
(3 h post-TBI) decreased to about 50% of that in controls but later
(6e24 h) it became increased (130%). Finally, at 7 d post-TBI the
level of the b3 became comparable to that in controls. In addition,
the protein level of the g2 was considerably increased (200% of that
in controls) at 3 h post-TBI, resembling the control values more
closely at later time points, except at 24 h post-TBI when it was only
about 30% of that in controls. These changes were inhibited by
injections of the NMDA receptor antagonist MK-801 prior to TBI.
Raible et al. (2012) induced TBI using lateral FPI in adult Spra-
gueeDawley rats. They found reduced levels of the a1-subunit
mRNA in whole hippocampal homogenates at 6 h post-TBI and
reduced levels of a1-subunit protein at 24 h, 48 h and 1 wk post-
TBI. Interestingly, the levels of the a4-subunit mRNA were
increased at 6 h post-TBI but an increase in the protein level was
found only at 24 h post-TBI, as the levels were below those of
controls at 1 wk post-TBI. The study of Kharlamov et al. (2011)
compared the hippocampal protein values of the a1, a4, g2 and
d subunits between controls, post-CCI SpragueeDawley rats with or
without spontaneous seizures at 7e11 months post-TBI. These in-
vestigators found a decreased protein expression level of g2 in the
rat group with PTE but an increased level of d in the subgroup of
rats without seizures. Thus the increased a4-subunit could be
assembled with a d-subunit. Also a4-containing GABAA receptors
without a g2 or d subunit may be possible (Bencsits et al., 1999).
How thalamic subunit changes presented here are comparable to
other TBI models remains to be studied as there is no literature
available.
We and other laboratories have shown a robust loss of presyn-
aptic interneurons in both the hippocampus and thalamus after
experimental TBI (Huusko and Pitkanen, 2014; Huusko et al., 2013;
Pavlov et al., 2011; Toth et al., 1997; Zhang et al., 2011a, 2011b).
Interestingly, however, surviving principal neurons of the hippo-
campus still maintain the normal gene expression of the GABAA
receptor subunits although GABAergic transmission is impaired
mainly due to presynaptic mechanisms (Pavlov et al., 2011). In the
thalamus, a massive neuronal loss (this study, Huusko and
Pitkanen, 2014) can be a major cause of decline in GABAA recep-
tor subunit mRNA levels ipsilaterally. However, to some extent a
down-regulation of the subunit gene expression may contribute to
the decreasing mRNA levels. Further, early changes in GABAA re-
ceptor subunit composition can indicate an impairment of
GABAergic transmission in the post-TBI tissue and may contribute
to its progressing neurodegeneration i.e. the extensive loss of PV
and GAD1 positive neurons in the RT may contribute to a pre- and
post-synaptic run-down of inhibition. Both, GAD1 and PV mRNA
levels were reduced in the RT after TBI consistent with the severe
damage seen also in the RT. It substantiates the severe unilateral
loss of GABA-ergic input to other thalamic nuclei in TBI, which may
be causatively related to the damage in these areas.
The g2-subunit, together with gephyrin and GABAA receptor
associated protein, appears to be crucial for the targeting of the
receptor complex in the membrane (Nymann-Andersen et al.,
2002). Thus after epileptic seizures it is rapidly internalized but
subsequently also rapidly re-synthetized and inserted into the
membrane (Naylor et al., 2005; Schwarzer et al., 1997; Tsunashima
et al., 1997). The observed lag in decline of g2 mRNA in this study
may reﬂect transient activation of g2 mRNA expression. Moreover,
the increased expression of a4 is reminiscent to its up-regulation in
animal models of temporal lobe epilepsy including electrically-
Fig. 7. Unsupervised hierarchical clustering of gene expression levels of 16 GABAA receptor subunits, Gad1 and Gad2 in controls and TBI animals at 6 months after insult when using
join type minimum. A heat map presents a level of gene expression of individual genes in the different brain areas. Every measured brain area had a unique gene expression pattern
of GABAA receptor subunits. A dendrogram in the left side of the ﬁgure indicates clustered subunits. Similarly, a dendrogram in the upper part of the ﬁgure shows clustering results
between individual animals, groups and the brain areas. Note that in the granule cell layer, the analysis separated TBI animals from controls. In addition, in the thalamus, we found
also a trend for separation. We did not ﬁnd any difference in the CA1 between TBI animals and controls. Abbreviations: GCL, granule cell layer; Gabra1, Gamma-aminobutyric acid
receptor subunit alpha-1; Gabra2, Gamma-aminobutyric acid receptor subunit alpha-2; Gabra3, Gamma-aminobutyric acid receptor subunit alpha-3; Gabra4, Gamma-aminobutyric
acid receptor subunit alpha-4; Gabra5, Gamma-aminobutyric acid receptor subunit alpha-5; Gabra6, Gamma-aminobutyric acid receptor subunit alpha-6; Gabrb2, Gamma-
aminobutyric acid receptor subunit beta-2; Gabrb3, Gamma-aminobutyric acid receptor subunit beta-3; Gabrd; Gamma-aminobutyric acid receptor subunit delta; Gabre,
Gamma-aminobutyric acid receptor subunit epsilon; Gabrg1, Gamma-aminobutyric acid receptor subunit gamma-1; Gabrg2, Gamma-aminobutyric acid receptor subunit gamma-2;
Gabrp, Gamma-aminobutyric acid receptor subunit pi; Gabrr1, Gamma-aminobutyric acid receptor subunit rho-1; Gabrr2, Gamma-aminobutyric acid receptor subunit rho-2; Gabrq,
Gamma-aminobutyric acid receptor subunit theta; Gad1, Glutamate decarboxylase1 (GAD67); Gad2, Glutamate decarboxylase 2 (GAD65); THA, thalamus.
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Sperk et al., 2004, 1998). Since up-regulation was seen especially
in the contralateral hemisphere it also reﬂects the strong impact of
TBI to the entire brain. The a4 subunit is mostly extra-synaptically
located and participates in tonic inhibition (Chandra et al., 2006;
Sieghart and Sperk, 2002). Its overexpression may be compensa-
tory for the reduced presynaptic GABAergic tone (Pavlov et al.,
2011) and could be part of a mechanism protecting the contralat-
eral hemisphere from brain damage. Our data indicate that this
seems to be even more obvious for the hippocampus where sub-
units a4 and a5 (extra-synaptically located; Zhang et al., 2007) are
up-regulated in the entire hippocampus at the late 4 months in-
terval. Messenger RNA levels of their presumptive “partners” in the
receptor complex, b3, g2 and d (Sieghart and Sperk, 2002) were
found to be close to control levels at 4 months post-TBI.
4.2. Level of the GABAB1 and GABAB2 mRNAs is decreased in the
thalamus but not in the hippocampus after lateral FPI
Presynaptic GABAB receptors are involved in the release of GABA
(Bowery et al., 2002). Moreover, postsynaptically these receptors
activate G protein-coupled, inwardly rectifying potassium (GIRK)
channels (Bowery et al., 2002). Recently, it has been revealed that
GABAB receptors can also modulate GABAA receptors via a post-
synaptic mechanism and thus regulate tonic inhibitory tone
(Connelly et al., 2013; Tao et al., 2013). After an initial down-
regulation we observed moderate up-regulation of both GABAB
receptor subunits in dentate granule cells 24 h after a status epi-
lepticus induced by kainic acid in rats and in patients with TLE
(Furtinger et al., 2003a, 2003b). Present study was the ﬁrst one
investigating the change in the GABAB receptor mRNA levels after
TBI. We found that besides a transient bilateral up-regulation ofGABAB2 mRNA in the granule cell layer 6 h after TBI and mild
decrease in the GABAB2 mRNA level at 4 months post-TBI, tran-
scripts of both GABAB receptor subunits did not signiﬁcantly change
in the hippocampus after TBI. In the thalamus, there was a marked
ipsilateral decrease of both subunit mRNAs in the most caudal part
of the PO/VPM/VPL complex already at 6 h post-TBI. One possibility
is that decreased mRNA levels may reﬂect underlying neuronal
damage in investigated areas.
4.3. Quantitative PCR array reproduced results from in situ
hybridization and revealed change in a pattern of GABAA receptor
gene expression after lateral FPI
In the present study, both assessments of the gene expression
level gave similar results and the ﬁndings were further proved by
immunohistochemical analysis. In the dentate gyrus and the hip-
pocampus when subunits on the PCR array were analyzed one by
one, only few of them reached the level of statistical signiﬁcance.
Interestingly, when we performed unsupervised hierarchical clus-
tering of all subunits in the granule cell layer or thalamus, we found
a change in the pattern of the subunit expression as the analysis
separated post-TBI animals from controls. This was not the case in
the CA1 subﬁeld of the hippocampus proper. For that reason, our
analysis suggests that after TBI in the granule cell layer and thal-
amus, there is a mild long-lasting GABAA receptor channelopathy
which is speciﬁc to particular brain areas. If these mild changes are
causing altered subunit composition affecting the receptor prop-
erties remains to be studied in more detail. However, the expres-
sion of GABAA receptor subunits seems to be under coordinated
control as it is well known that particular subunits are co-expressed
and one can suggest that they share regulatory elements for gene
expression (Bailey et al., 1999).
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Our study shows complex changes in the constitution of GABAA
receptors developing in a ﬁrst step rather fast (hours or a few
days) and are compensated in hippocampus but not in the thal-
amus in the chronic phase. Does this leave a window for inter-
vention with the pathophysiological events after TBI (e.g.
neurodegeneration, development of epilepsy) by augmenting
inhibitory transmission through GABAA receptors? GABAergic in-
hibition involves different cellular mechanisms: 1) Phasic inhibi-
tion mediated by synaptically located GABAA receptors mostly
assembled by a1-, a2-or a3-, either b- and a g2-subunit. 2) Tonic
inhibition through high afﬁnity GABAA receptors located peri- or
extrasynaptically and containing a4-, a5-, either b- and a d-sub-
unit. Interestingly, tonic GABAergic inhibition appears to be pre-
served or even increased in animal models of TLE (Scimemi et al.,
2005; Zhang et al., 2007) although the a5 and d subunits become
widely down-regulated (Drexel et al., 2013; Nishimura et al., 2005;
Sperk et al., 1998; Tsunashima et al., 1997). One explanation for
this could be a shift of the g2-subunit from receptors at synaptic
sites to receptors located at peri- and extra-synaptic sites (Zhang
et al., 2007). There they may assemble together with a4-
subunits that are often preserved in the hippocampus of
epileptic rats (Drexel et al., 2013; Sperk et al., 1998).
As mentioned above, in contrast to mRNA levels of subunits a1
and a2 (mediating phasic inhibition) which were comparable to
control values in the present study, a4 and a5 subunits (mediating
tonic inhibition) become up-regulated in the hippocampus at late
intervals after TBI. At these time points, levels of their potential
partners, subunits b2, g2 and d, were unaltered or also up-
regulated. Similarly, in the contralateral thalamus, the receptor
conﬁgurations consisted of up-regulated a4 subunit and unaltered
g2 or d subunits. Thus, a therapeutic approach targeting preferen-
tially extra-synaptic, a4, a5 and d containing GABAA receptors may
be promising for augmenting inhibition both in the hippocampus
and in the thalamus. Endogenously produced neurosteroids are
modulating GABAA receptors through d-subunit whereas classical
benzodiazepines augment GABAergic transmission via an interac-
tion with the g2 subunit. Neurosteroids like allopregnanolone,
allotetrahydrodeoxycorticosterone, and androstanediol as well as
progesterone and deoxycorticosterone (that are converted to neu-
rosteroids) exert potent anticonvulsant properties in a variety of
animal models of epilepsy (for review see Reddy, 2011). Whether
neurosteroids have an inﬂuence on the pathophysiology of early
brain damage and on development of secondary epilepsy after TBI
remains to be studied. O'Dell et al. (2000) studied an approach of
activating g2 subunit containing receptors. Authors observed that
treatment with diazepam 15 min prior or 15 min after TBI pre-
vented learning deﬁcits in the Morris maze. Since survival was
improved only in rats treated with diazepam prior to TBI these
effects seem to be restricted to the very acute phase. It may be
reasonable to consider also a combination therapy or stepwise
therapy with diazepam and neurosteroids. Because of changes in
the expression of chloride transporters NKCC1 and KCC2 in epilepsy
the chloride gradient over the neuronal membrane may be altered
and may result in an excitatory instead of an inhibitory action of
GABA at GABAA receptors (Huberfeld et al., 2007; Rivera et al.,
2004). A similar mechanism has also been suggested for TBI
(Bonislawski et al., 2007). Thus inhibiting NKCC1 (the chloride
transporter thought to transport chloride into the cell) with the
selective inhibitor bumetanide results in anticonvulsive actions in
some models (Ben-Ari and Tyzio, 2011) and may be even disease
modifying in pilocarpine treated animals. Interestingly, phenobar-
bital acting through GABAA receptors seems to have synergistic
effects (Brandt et al., 2010).5. Conclusion
We investigated the time course of mRNA levels of major GABAA
and GABAB receptor subunits in hippocampus and thalamus after
TBI in the rat. Most GABAA receptor subunits were transiently
down-regulated bilaterally in the hippocampus in acute time
points. In contrast, in the thalamus mRNA concentrations of all
GABAA receptor subunits investigated become rapidly but irre-
versibly reduced. These thalamic changes were, however, restricted
to the ipsilateral side. Whereas the changes in the thalamus may be
partly due to the tissue damage, those in the hippocampus seem to
reﬂect TBI related changes in the gene expression. Noteworthy,
delayed decreases in g2 and d subunit ipsilaterally and increased
subunit a4 mRNA levels contralaterally indicate compensatory
changes on the gene expression of the GABAA receptor subunits. In
addition, bioinformatics analysis of the RT-PCR array suggested
mild GABAA receptor channelopathy, particularly in the granule cell
layer. Finally, we suggest augmentation of GABAergic transmission
with neurosteroids acting through d-containing receptors as
possible strategy.
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